Cheng S. Quah

1.8k citations
30 papers · 1.3k indexed · 1 hit paper · h-index 14
Topics
Chronic Lymphocytic Leukemia Research (11 papers)HER2/EGFR in Cancer Research (9 papers)Cancer Treatment and Pharmacology (7 papers)

In The Last Decade

Cheng S. Quah

30 papers receiving 1.3k citations

Hit Papers

ASCEND: Phase III, Randomized Trial of Acalabrutinib Vers...2020202620222024202050100150200250

Peers

Cheng S. Quah
Comparison fields: 5 of 80
  • Oncology 540
  • Genetics 451
  • Pulmonary and Respiratory Medicine 363
  • Pathology and Forensic Medicine 340
  • Surgery 224
Replace Veena Charu with:
Veena Charu United States
Anton Roth Poland
Pascal Wolter Belgium
Peter Wood Australia
Johann Pidlich Austria
Elliot Newman United States
Yun‐Gyoo Lee South Korea
Thomas B. Neff United States
W. Qian United Kingdom
Maria Antonietta Aloe Spiriti Italy
Cheng S. Quah relative to Veena Charu United States Veena Charu's profile →
Citations per field
00.5×7.6×
Veena Charu · 1×
Citations per year

Countries citing papers authored by Cheng S. Quah

Since Specialization
Citations

This map shows the geographic impact of Cheng S. Quah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng S. Quah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng S. Quah more than expected).

Fields of papers citing papers by Cheng S. Quah

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng S. Quah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng S. Quah. The network helps show where Cheng S. Quah may publish in the future.

Co-authorship network of co-authors of Cheng S. Quah

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng S. Quah. A scholar is included among the top collaborators of Cheng S. Quah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng S. Quah. Cheng S. Quah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 9
2 1
3 1
4 76
5 4
6
ASCEND: Phase III, Randomized Trial of Acalabrutinib Versus Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemiabreakdown →
252
7 57
8 8
9 1
10 8
11 2
12 92
13 7
14 17
15 61
16 51
17 175
18 57
19 45
20 225

About Cheng S. Quah

Cheng S. Quah is a scholar working on Genetics, Physiology and Oncology, having authored 30 papers that have together received 1.3k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (11 papers), HER2/EGFR in Cancer Research (9 papers) and Cancer Treatment and Pharmacology (7 papers). The work is most often cited by research in Genetics (451 citations), Anesthesiology and Pain Medicine (175 citations) and Oncology (540 citations). Cheng S. Quah has collaborated with scholars based in United States, Poland and South Korea. Frequent co-authors include Jana Hudcova, Daniel B. Carr, Joseph Lau, Ewan D McNicol, David Miles, Denise A. Yardley, Sandra M. Swain, Young‐Hyuck Im, Javier Cortés and José Baselga. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Cochrane Database of Systematic Reviews.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026